Literature DB >> 16250800

Psychophysiological effects of habitual caffeine consumption.

J E James1.   

Abstract

Caffeine is the most widely consumed pharmacologically active substance in the world, and a key issue concerning its possible implications for human health is whether it has persistent (i.e., chronic) physiological effects on habitual consumers. This study examined blood pressure, heart rate (HR), electromyogram (EMG), and skin conductance level (SCL) in 36 healthy men and women exposed to a pattern of moderate intake. A double-blind placebo-controlled crossover design with counterbalancing was used in which all subjects participated in four experimental conditions involving the ingestion of placebo or caffeine three times daily for 6 days followed by a seventh ("challenge") day of placebo or caffeine ingestion. Results confirmed that caffeine has significant pressor effects, and these were found to he additive to the pressor action of a laboratory stressor. Following habitual consumption of the drug. pressor effects were diminished (indicative of tolerance) but not eliminated. Effects of caffeine on other parameters were either modest (HR and EMG) or negligible (SCL). Considering (he near-universal use of caffeine. the persistent pressor effects observed in this study have important implications for clinical practice and public health.

Entities:  

Year:  1994        PMID: 16250800     DOI: 10.1207/s15327558ijbm0103_5

Source DB:  PubMed          Journal:  Int J Behav Med        ISSN: 1070-5503


  37 in total

1.  Assessment of four ambulatory blood pressure monitors and measurements by clinicians versus intraarterial blood pressure at rest and during exercise.

Authors:  W B White; P Lund-Johansen; P Omvik
Journal:  Am J Cardiol       Date:  1990-01-01       Impact factor: 2.778

2.  The effect of memory load on the circadian variation in performance efficiency under a rapidly rotating shift system.

Authors:  S Folkard; P Knauth; T H Monk
Journal:  Ergonomics       Date:  1976-07       Impact factor: 2.778

3.  Persistent cardiovascular effects with repeated caffeine administration.

Authors:  J D Lane; D C Manus
Journal:  Psychosom Med       Date:  1989 Jul-Aug       Impact factor: 4.312

4.  The role of epinephrine in the circulatory effects of coffee.

Authors:  P Smits; G Pieters; T Thien
Journal:  Clin Pharmacol Ther       Date:  1986-10       Impact factor: 6.875

5.  Circulatory effects of coffee in relation to the pharmacokinetics of caffeine.

Authors:  P Smits; T Thien; A van't Laar
Journal:  Am J Cardiol       Date:  1985-12-01       Impact factor: 2.778

Review 6.  Clinical pharmacology of caffeine.

Authors:  N L Benowitz
Journal:  Annu Rev Med       Date:  1990       Impact factor: 13.739

7.  Effects of caffeine on pressor regulation during rest and exercise in men at risk for hypertension.

Authors:  G A Pincomb; M F Wilson; B H Sung; R B Passey; W R Lovallo
Journal:  Am Heart J       Date:  1991-10       Impact factor: 4.749

8.  Assessment of caffeine exposure: caffeine content of beverages, caffeine intake, and plasma concentrations of methylxanthines.

Authors:  A Lelo; J O Miners; R Robson; D J Birkett
Journal:  Clin Pharmacol Ther       Date:  1986-01       Impact factor: 6.875

9.  Chronic effects of habitual caffeine consumption on laboratory and ambulatory blood pressure levels.

Authors:  J E James
Journal:  J Cardiovasc Risk       Date:  1994-08

Review 10.  The health consequences of caffeine.

Authors:  P W Curatolo; D Robertson
Journal:  Ann Intern Med       Date:  1983-05       Impact factor: 25.391

View more
  2 in total

1.  Effects of caffeine on performance and mood: withdrawal reversal is the most plausible explanation.

Authors:  Jack E James; Peter J Rogers
Journal:  Psychopharmacology (Berl)       Date:  2005-07-02       Impact factor: 4.530

2.  Caffeine improves reaction time, vigilance and logical reasoning during extended periods with restricted opportunities for sleep.

Authors:  Gary H Kamimori; Tom M McLellan; Charmaine M Tate; David M Voss; Phil Niro; Harris R Lieberman
Journal:  Psychopharmacology (Berl)       Date:  2014-12-21       Impact factor: 4.530

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.